Welcome to the new GOED website!

| More

By: Ellen Schutt

Welcome to the new GOED website. This has been a long time in coming and we are very excited about the new functionality and user-friendliness built in to the site. The big new highlight on the main site is the expanded directory of member companies, which will help our members and the larger industry learn more about GOED members’ capabilities and offerings.  Go to the “Find a Member” tab under Our Members to start your search.

Zombie ideas

| More

By: Adam Ismail

Zombie ideas

Paul Krugman, the Nobel Prize-winning economist, recently wrote a column about a zombie idea, which he defines as “an idea that should have been killed by evidence, but refuses to die.” I would argue that we have zombie ideas in the omega-3 space as well. The most prevalent is the recent deluge of studies from cardiologists and doctors that purport to show omega-3s are not beneficial for cardiovascular disease. Perhaps EPA and DHA are maligned because of their association with the broader dietary supplement industry, which is not trusted by doctors or consumers, but that should not blind researchers from examining the evidence objectively. 

How can we combat “omega-3 fatigue” in the media?

| More

By: Ellen Schutt

How can we combat “omega-3 fatigue” in the media?

 

GOED’s recently-commissioned meta analysis linking omega-3 intake to a reduction in blood pressure was very exciting for us and for our members. Lead author Dominik Alexander, principal epidemiologist at Exponent, said that it’s rare to see such a large body of research (70 studies) with such a consistent result. Additionally, the message that consuming omega-3s can help reduce blood pressure as much as other common lifestyle changes like reducing sodium or alcohol intake and increasing physical activity is an easy one for consumers to understand.

Is the time for eye health coming?

| More

By: Adam Ismail

Is the time for eye health coming?

Back in 2010, I remember sitting at a conference listening to Dr. Jeffrey Anshel from the Ocular Nutrition Society talk about the benefits of omega-3s in eye health. The gist of the talk was that omega-3s are an important part of the eye, which is something most ophthalmologists have recognized for years.  However, this position had been developed without any human clinical trials having been published to date. So why exactly is that?

Dr. Jay Udani, SELECT investigator, comments on prostate cancer study

| More

By: Adam Ismail

In GOED’s continuing response to the recent study linking omega-3s to prostate cancer risk, we recently interviewed Dr. Jay Udani, CEO and founder of Medicus Research, and an investigator on the original SELECT study upon which this paper was based. Dr. Udani shares his unique perspective and corroborates the many criticisms of the study. See what he had to say:

Omega-3s and prostate cancer risk

| More

By: Adam Ismail

As many of you know, a study was published earlier this week linking omega-3s to an increased risk of prostate cancer. GOED has reviewed the study an prepared the analysis of the scientific inaccuracies and study design issues below. In addition, Adam Ismail wrote a more consumer-friendly blog column that was published this morning on Virgo's Omega-3 Insights page. We thought this would be useful for GOED members to share with concerned customers and consumers.